Protenus Revenue and Competitors

Location

$57.2M

Total Funding

Estimated Revenue & Valuation

  • Protenus's estimated annual revenue is currently $15M per year.(i)
  • Protenus received $11.0M in venture funding in January 2018.
  • Protenus's estimated revenue per employee is $140,000
  • Protenus's total funding is $57.2M.

Employee Data

  • Protenus has 107 Employees.(i)
  • Protenus grew their employee count by -3% last year.

Protenus's People

NameTitleEmail/Phone
1
Co-FounderReveal Email/Phone
2
CFOReveal Email/Phone
3
CEO, Co-FounderReveal Email/Phone
4
VP Customer Success & ServicesReveal Email/Phone
5
General CounselReveal Email/Phone
6
VP SalesReveal Email/Phone
7
VP SalesReveal Email/Phone
8
ControllerReveal Email/Phone
9
Marketing DirectorReveal Email/Phone
10
Chief Marketing OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.9M4610%$60MN/A
#2
$16.2M11211%N/AN/A
#3
$6.5M53-9%N/AN/A
#4
$2.4M24N/AN/AN/A
#5
$88.9M3439%$1.1M$5B
#6
$14M1002%N/AN/A
#7
$1.4M16N/AN/AN/A
#8
$0.6M8N/AN/AN/A
#9
$14.1M58N/AN/AN/A
#10
$0.3M4N/AN/AN/A
#11
$21.6M80N/AN/AN/A
#12
$1.1M8N/AN/AN/A
#13
$24.3M119-14%$50.4MN/A
Add Company

What Is Protenus?

Protenus helps healthcare leaders gain full insight into how health data is being used. We alert privacy, security and compliance teams to inappropriate activity in real-time, and help our partner hospitals make decisions about how to better protect their data, their patients, and their institutions. Our solution is a lightweight analytical tool focused on protecting against insider threats. Built for overburdened hospital compliance & security officers, our analytics filter through the millions of activities that take place in a hospital every day in order to proactively identify HIPAA violations, incidents of drug diversion, and more. Our solution deeply understands how patient data should be used and, as a result, can accurately determine when it is used improperly. We promise to help hospital compliance officers sleep soundly at night, knowing that all hospital employees are only using data within the bounds of their clinical or administrative responsibilities. For Compliance Officers Our solution helps you save time, reduce false positives, and stay compliant by proactively flagging potential HIPAA violations, incidents of clinical drug diversion, and more, drastically reducing investigation time. For the Hospital or Institution Our solution minimizes the risk of lawsuits, fines, and reputational damage associated with unaddressed HIPAA violations, clinical drug diversion, and more, ultimately keeping patient data safer and keeping our customers out of the headlines. For the Community Our solution ensures that patient information is only accessed for the right reasons, restoring trust between patients and providers.

keywords:saas, Analytics,Enterprise Software,Health It,Healthcare,Healthcare Providers,Information Security,Pharmaceuticals,Security

$57.2M

Total Funding

107

Number of Employees

$15M

Revenue (est)

-3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Protenus News

2022-04-13 - Protenus Granted New Patent 'Methods and Systems for ...

Protenus' drug diversion patents cover various techniques for detecting anomalous drug dispensing events. Covered techniques include clustering...

2022-04-06 - On-the-Spot Intervention 95% Effective in Reducing ...

BALTIMORE, April 13, 2022 (GLOBE NEWSWIRE) -- Protenus is pleased to announce a recent study found that on-the-spot interventions for...

2022-03-30 - Protenus Focuses on Technology and Customers as It ...

BALTIMORE, April 04, 2022 (GLOBE NEWSWIRE) -- Protenus, the nation's leading healthcare compliance analytics platform, announced today the...

2019-09-08 - Healthcare Embracing New Era of Compliance and Analytics

BALTIMORE, Aug. 20, 2019 /PRNewswire/ -- Healthcare compliance analytics company Protenus today announced a $17M investment from ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75M1077%N/A
#2
$16.1M1074%N/A
#3
$35M10722%N/A
#4
$37.5M107-20%N/A
#5
$3.5M1074%N/A

Protenus Funding

DateAmountRoundLead InvestorsReference
2017-07-20$3.0MAKaiser Permanente VenturesArticle
2018-01-23$11.0MBF-Prime Capital PartnersArticle